Karishma Amin Bhardwaj, NP
Nurse Practitioner · Walnut Creek
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · John Muir Physician Network · 488 clinicians in this group
Hospitals listed: 057276 · John Muir Medical Center - Concord Campus · John Muir Medical Center - Walnut Creek Campus. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Karishma Amin Bhardwaj’s office at (925) 947-0417 to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- John Muir Medical Center - Concord CampusConcord, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.235, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.675, Oct 2024 – Sep 2025
- John Muir Medical Center - Walnut Creek CampusWalnut Creek, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 2.01 (1.17 to 2.85) · 2,206 cases, Jul 2022 – Jun 2024Worse than the national rate — Death rate among surgical inpatients with serious treatable complications: 222.42 (177.82 to 267.02) · 120 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.4 (0.91 to 1.9) · 9,764 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Colon Surgery: 2.734, Oct 2024 – Sep 2025Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.536, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.341, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.455, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.245, Oct 2024 – Sep 2025
See every measure and the patient survey for John Muir Medical Center - Concord Campus
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.235 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.675 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.11 (0.21 to 2) · 1,612 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.77 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 184.13 (136.65 to 231.6) · 86 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.2 · 175 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.4 · 172 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8 · 537 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 434 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13 · 215 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,208 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.32 (0.13 to 0.51) · 7,626 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,660 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.1 (1.29 to 4.91) · 2,723 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.21 (0 to 2.51) · 1,208 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3 (1.7 to 4.3) · 2,355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.77 (3.24 to 12.3) · 1,216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.43 (0.43 to 6.43) · 1,253 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.93 (0.47 to 3.4) · 388 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.14 (0.58 to 1.69) · 6,288 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 263 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.636 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.254 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.904 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 312 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.1 · 768 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -6.8 · 295 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.1 · 648 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 31.1 · 433 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 504 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.7 (5.1 to 8.8) · 476 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.9 (10.5 to 15.7) · 476 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 8.8 · 154 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.7 · 186 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (9.9 to 17.9) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.2) · 546 cases | No different | Jan 2024 – Dec 2024 |
What patients said (521 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
See every measure and the patient survey for John Muir Medical Center - Walnut Creek Campus
Behind the star rating — Deaths: 3 better, 2 the same, 2 worse of 7 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 3 better, 5 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 2.01 (1.17 to 2.85) · 2,206 cases | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 222.42 (177.82 to 267.02) · 120 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.4 (0.91 to 1.9) · 9,764 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 2.734 | Worse | Oct 2024 – Sep 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.536 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.341 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.455 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.245 | Better | Oct 2024 – Sep 2025 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.87 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 131 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 695 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.5 · 827 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.1 · 509 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 4,483 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.35 (0.18 to 0.53) · 11,630 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.05 to 0.39) · 11,793 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.69 to 4.96) · 3,268 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.37 (0 to 2.94) · 1,631 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.76 (1.43 to 4.09) · 3,066 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.12 (0.22 to 12.02) · 1,580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.43 (1.21 to 7.64) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 685 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 615 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.88 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 93 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 729 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.1 · 91 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13 · 736 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 34.8 · 842 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 818 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.4) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.2 to 15.5) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 584 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 139 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.9) · 222 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 321 cases | No different | Jan 2024 – Dec 2024 |
What patients said (758 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$32,567
Medicare paid this office $32,567 for 175 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 107 | $8,756 | $56 |
| Short return visit (20+ min) | 94 | $5,596 | $51 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 17 | $4,965 | $292 |
| Sarscv2 vac 30mcg trs-suc im | 15 | $1,927 | $128 |
| Influenza vaccine split virus, preservative free | 18 | $1,473 | $82 |
See all 12 services
| Return visit (30+ min) | 107 | $8,756 | $56 |
| Short return visit (20+ min) | 94 | $5,596 | $51 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 17 | $4,965 | $292 |
| Sarscv2 vac 30mcg trs-suc im | 15 | $1,927 | $128 |
| Influenza vaccine split virus, preservative free | 18 | $1,473 | $82 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 67 | $1,386 | $21 |
| Admn sarscov2 vacc 1 dose | 24 | $1,290 | $52 |
| Administration of influenza virus vaccine | 19 | $735 | $39 |
| Administration of pneumococcal vaccine | 17 | $658 | $39 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 42 | $644 | $12 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 27 | $310 | $11 |
| Urinalysis, manual test | 15 | $55 | $3 |
Who their Medicare patients are
175 Original Medicare patients in 2024. Average age 74 · Women 83% · Health risk score 0.80. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 62% · Diabetes 15% · Depression 15% · Coronary heart disease 13% · Atrial fibrillation 13% · Chronic kidney disease 11% · Cancer 11%.
The office billed $137,729, Medicare allowed $41,734 and paid $32,567; for 639 services of 37 kinds; $10,394 of it was for drugs given in the office and $22,173 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 175 | 639 | 74 | 0.80 | $137,729 | $32,567 |
| 2023 | 106 | 229 | 74 | 0.91 | $52,999 | $11,374 |
| 2022 | 243 | 601 | 74 | 0.83 | $121,617 | $30,412 |
| 2021 | 252 | 997 | 74 | 0.86 | $124,310 | $34,085 |
| 2020 | 141 | 283 | 73 | 0.77 | $48,874 | $16,223 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 60 | $4,123 | $56 |
| Short return visit (20+ min) | 36 | $1,813 | $46 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 27 | $675 | $25 |
| Short return visit | 14 | $665 | $47 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 16 | $118 | $7 |
2022: 11 services
| Return visit (30+ min) | 100 | $7,611 | $59 |
| Short return visit (20+ min) | 90 | $5,143 | $49 |
| Short return visit | 79 | $3,754 | $44 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 72 | $3,502 | $49 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 27 | $1,893 | $70 |
| Long return visit (40+ min) | 13 | $1,416 | $109 |
| Administration of influenza virus vaccine | 27 | $828 | $31 |
| Administration of pneumococcal vaccine | 14 | $431 | $31 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 36 | $348 | $10 |
| Removal of impacted ear wax by washing | 11 | $137 | $11 |
| Urinalysis, manual test | 17 | $62 | $3 |
2021: 12 services
| Return visit (30+ min) | 93 | $8,233 | $67 |
| Short return visit (20+ min) | 119 | $7,665 | $53 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 56 | $5,252 | $94 |
| Long return visit (40+ min) | 19 | $1,678 | $88 |
| Short return visit | 38 | $1,625 | $42 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 22 | $1,456 | $66 |
| Pneumococcal vaccine, 23-valent | 11 | $1,385 | $126 |
| New patient visit (30+ min) | 19 | $778 | $41 |
| Administration of influenza virus vaccine | 31 | $554 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 28 | $336 | $11 |
| Administration of pneumococcal vaccine | 12 | $213 | $18 |
| Urinalysis, manual test | 25 | $94 | $3 |
2020: 7 services
| Short return visit (20+ min) | 84 | $5,962 | $56 |
| Return visit (30+ min) | 44 | $3,861 | $86 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $1,420 | $118 |
| Telephone medical discussion with physician, 11-20 minutes | 21 | $1,149 | $44 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 17 | $1,037 | $61 |
| Administration of influenza virus vaccine | 19 | $391 | $21 |
| Urinalysis, manual test | 12 | $45 | $3 |
Drugs they prescribed that Part D paid
$145,225
Pharmacies billed $145,225 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,256 generic and fewer than 11 brand-name prescriptions · $145,225 in drug cost · 84 antibiotic prescriptions to 72 people · 12 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 34 | $31,795 | $935 |
| Arnuity Ellipta | 11 | $3,488 | $317 |
| Rosuvastatin | 103 | $2,938 | $29 |
| Synthroid | 23 | $1,826 | $79 |
| Levothyroxine | 142 | $1,749 | $12 |
See all 58 drugs
| Ozempic | 34 | $31,795 | $935 |
| Arnuity Ellipta | 11 | $3,488 | $317 |
| Rosuvastatin | 103 | $2,938 | $29 |
| Synthroid | 23 | $1,826 | $79 |
| Levothyroxine | 142 | $1,749 | $12 |
| Atorvastatin | 149 | $1,660 | $11 |
| Metoprolol | 78 | $1,394 | $18 |
| Fluticasone-Salmeterol | 12 | $1,279 | $107 |
| Gabapentin | 42 | $1,034 | $25 |
| Lisinopril | 107 | $1,022 | $10 |
| Estradiol | 20 | $1,014 | $51 |
| Losartan | 98 | $1,009 | $10 |
| Duloxetine | 34 | $922 | $27 |
| Trazodone | 35 | $738 | $21 |
| Simvastatin | 72 | $704 | $10 |
| Albuterol Sulfate Hfa | 25 | $666 | $27 |
| Amlodipine Besylate | 120 | $651 | $5 |
| Celecoxib | 11 | $649 | $59 |
| Metformin | 55 | $600 | $11 |
| Bupropion Xl | 23 | $566 | $25 |
| Bupropion Hcl Sr | 11 | $562 | $51 |
| Escitalopram | 30 | $428 | $14 |
| Montelukast | 23 | $387 | $17 |
| Ezetimibe | 11 | $361 | $33 |
| Clopidogrel | 17 | $361 | $21 |
| Sumatriptan | 37 | $347 | $9 |
| Sertraline | 29 | $331 | $11 |
| Valacyclovir | 19 | $319 | $17 |
| Pantoprazole | 29 | $295 | $10 |
| Valsartan-Hydrochlorothiazide | 12 | $278 | $23 |
| Zolpidem | 46 | $247 | $5 |
| Hydrochlorothiazide | 42 | $232 | $6 |
| Pravastatin | 18 | $220 | $12 |
| Omeprazole | 29 | $218 | $8 |
| Lisinopril-Hydrochlorothiazide | 14 | $198 | $14 |
| Diclofenac | 12 | $196 | $16 |
| Metoprolol | 12 | $174 | $15 |
| Famotidine | 13 | $168 | $13 |
| Buspirone | 17 | $152 | $9 |
| Triamterene-Hydrochlorothiazid | 20 | $149 | $7 |
| Clotrimazole-Betamethasone | 12 | $147 | $12 |
| Atenolol | 13 | $143 | $11 |
| Fluoxetine | 15 | $108 | $7 |
| Furosemide | 17 | $94 | $6 |
| Meloxicam | 20 | $88 | $4 |
| Alendronate | 16 | $87 | $5 |
| Lorazepam | 25 | $80 | $3 |
| Cephalexin | 17 | $79 | $5 |
| Allopurinol | 13 | $70 | $5 |
| Temazepam | 12 | $66 | $5 |
| Nabumetone | 12 | $64 | $5 |
| Azithromycin | 15 | $55 | $4 |
| Paroxetine | 14 | $54 | $4 |
| Alprazolam | 16 | $42 | $3 |
| Cyclobenzaprine | 14 | $33 | $2 |
| Quetiapine | 12 | $32 | $3 |
| Diazepam | 15 | $29 | $2 |
| Carisoprodol | 12 | $25 | $2 |
Year by year
| 2024 | 2,479 | 362 | None | None | $145,225 |
| 2023 | 2,182 | 345 | 1% (11) | 8% | $152,093 |
| 2022 | 2,065 | 376 | 1% (15) | 10% | $129,036 |
| 2021 | 1,662 | 471 | 2% (34) | 12% | $103,094 |
| 2020 | 586 | 261 | None | None | $43,613 |
| 2019 | 19 | 14 | None | None | $1,644 |
| 2018 | 15 | 11 | None | None | $1,607 |
| 2017 | 41 | 25 | 42% (17) | None | $913 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 53 drugs
| Myrbetriq | 26 | $24,682 | $949 |
| Xarelto | 13 | $17,549 | $1,350 |
| Ozempic | 12 | $12,269 | $1,022 |
| Rosuvastatin | 65 | $2,622 | $40 |
| Levothyroxine | 100 | $1,857 | $19 |
| Estradiol | 18 | $1,373 | $76 |
| Atorvastatin | 127 | $1,314 | $10 |
| Synthroid | 13 | $1,305 | $100 |
| Losartan | 74 | $1,292 | $17 |
| Metoprolol | 57 | $1,047 | $18 |
| Trazodone | 51 | $894 | $18 |
| Amlodipine Besylate | 98 | $861 | $9 |
| Lisinopril | 95 | $836 | $9 |
| Gabapentin | 33 | $824 | $25 |
| Fluoxetine | 18 | $785 | $44 |
| Bupropion Xl | 30 | $720 | $24 |
| Simvastatin | 59 | $642 | $11 |
| Montelukast | 27 | $552 | $20 |
| Duloxetine | 18 | $512 | $28 |
| Sumatriptan | 46 | $492 | $11 |
| Metformin | 42 | $490 | $12 |
| Pantoprazole | 34 | $481 | $14 |
| Celecoxib | 14 | $470 | $34 |
| Diclofenac | 19 | $391 | $21 |
| Omeprazole | 26 | $386 | $15 |
| Albuterol Sulfate Hfa | 15 | $343 | $23 |
| Carisoprodol | 12 | $293 | $24 |
| Escitalopram | 25 | $260 | $10 |
| Triamcinolone Acetonide | 11 | $239 | $22 |
| Donepezil | 16 | $224 | $14 |
| Lorazepam | 36 | $222 | $6 |
| Pravastatin | 13 | $220 | $17 |
| Famotidine | 16 | $215 | $13 |
| Hydrochlorothiazide | 41 | $210 | $5 |
| Alendronate | 17 | $193 | $11 |
| Metoprolol | 13 | $180 | $14 |
| Sertraline | 16 | $180 | $11 |
| Triamterene-Hydrochlorothiazid | 11 | $172 | $16 |
| Atenolol | 14 | $169 | $12 |
| Buspirone | 16 | $167 | $10 |
| Zolpidem | 39 | $163 | $4 |
| Lovastatin | 12 | $163 | $14 |
| Citalopram Hbr | 14 | $149 | $11 |
| Lisinopril-Hydrochlorothiazide | 13 | $140 | $11 |
| Azithromycin | 14 | $106 | $8 |
| Acyclovir | 13 | $103 | $8 |
| Alprazolam | 15 | $73 | $5 |
| Quetiapine | 14 | $72 | $5 |
| Meloxicam | 19 | $72 | $4 |
| Cephalexin | 11 | $71 | $6 |
| Ciprofloxacin | 11 | $67 | $6 |
| Allopurinol | 11 | $66 | $6 |
| Ibuprofen | 11 | $33 | $3 |
2022: 46 drugs
| Myrbetriq | 22 | $18,253 | $830 |
| Levothyroxine | 113 | $2,278 | $20 |
| Atorvastatin | 142 | $1,639 | $12 |
| Bupropion Xl | 31 | $1,266 | $41 |
| Diltiazem 24hr Er (Cd) | 12 | $1,211 | $101 |
| Fluoxetine | 20 | $1,129 | $56 |
| Estradiol | 12 | $1,128 | $94 |
| Metoprolol | 50 | $1,005 | $20 |
| Losartan | 78 | $894 | $11 |
| Lisinopril | 92 | $870 | $9 |
| Trazodone | 53 | $869 | $16 |
| Gabapentin | 42 | $789 | $19 |
| Montelukast | 30 | $713 | $24 |
| Sumatriptan | 47 | $658 | $14 |
| Celecoxib | 11 | $591 | $54 |
| Rosuvastatin | 39 | $589 | $15 |
| Quetiapine | 27 | $553 | $20 |
| Pantoprazole | 31 | $543 | $18 |
| Albuterol Sulfate Hfa | 12 | $517 | $43 |
| Duloxetine | 11 | $441 | $40 |
| Valacyclovir | 20 | $425 | $21 |
| Omeprazole | 21 | $388 | $18 |
| Simvastatin | 41 | $360 | $9 |
| Diclofenac | 12 | $338 | $28 |
| Amlodipine Besylate | 71 | $322 | $5 |
| Tamsulosin | 12 | $256 | $21 |
| Atenolol | 19 | $248 | $13 |
| Fluticasone Propionate | 15 | $240 | $16 |
| Citalopram Hbr | 16 | $237 | $15 |
| Carisoprodol | 12 | $232 | $19 |
| Hydrochlorothiazide | 32 | $231 | $7 |
| Alendronate | 18 | $229 | $13 |
| Escitalopram | 19 | $218 | $11 |
| Metformin | 27 | $213 | $8 |
| Cyclobenzaprine | 14 | $189 | $13 |
| Lovastatin | 15 | $182 | $12 |
| Famotidine | 22 | $171 | $8 |
| Zolpidem | 23 | $167 | $7 |
| Donepezil | 17 | $151 | $9 |
| Lorazepam | 41 | $150 | $4 |
| Paxlovid (Eua) | 14 | $130 | $9 |
| Cephalexin | 14 | $102 | $7 |
| Azithromycin | 15 | $99 | $7 |
| Buspirone | 15 | $80 | $5 |
| Alprazolam | 28 | $80 | $3 |
| Meloxicam | 11 | $46 | $4 |
2021: 40 drugs
| Myrbetriq | 15 | $18,554 | $1,237 |
| Levothyroxine | 108 | $2,372 | $22 |
| Clorazepate Dipotassium | 19 | $1,517 | $80 |
| Atorvastatin | 92 | $1,116 | $12 |
| Bupropion Xl | 14 | $1,106 | $79 |
| Rosuvastatin | 18 | $845 | $47 |
| Synthroid | 11 | $820 | $75 |
| Trazodone | 43 | $748 | $17 |
| Albuterol Sulfate Hfa | 14 | $745 | $53 |
| Metoprolol | 26 | $736 | $28 |
| Losartan | 54 | $648 | $12 |
| Lisinopril | 70 | $632 | $9 |
| Fluoxetine | 11 | $566 | $51 |
| Gabapentin | 33 | $509 | $15 |
| Sumatriptan | 30 | $473 | $16 |
| Valacyclovir | 12 | $455 | $38 |
| Pantoprazole | 18 | $430 | $24 |
| Diclofenac | 18 | $396 | $22 |
| Amlodipine Besylate | 57 | $372 | $7 |
| Montelukast | 17 | $370 | $22 |
| Escitalopram | 22 | $336 | $15 |
| Metformin | 32 | $307 | $10 |
| Nitrofurantoin Mono-Macro | 20 | $300 | $15 |
| Fluticasone Propionate | 12 | $291 | $24 |
| Atenolol | 25 | $276 | $11 |
| Simvastatin | 26 | $275 | $11 |
| Omeprazole | 15 | $245 | $16 |
| Zolpidem | 35 | $244 | $7 |
| Hydrocodone-Acetaminophen | 13 | $213 | $16 |
| Triamcinolone Acetonide | 15 | $212 | $14 |
| Quetiapine | 18 | $212 | $12 |
| Sertraline | 15 | $204 | $14 |
| Citalopram Hbr | 11 | $192 | $17 |
| Hydrochlorothiazide | 35 | $145 | $4 |
| Lorazepam | 32 | $111 | $3 |
| Cyclobenzaprine | 17 | $94 | $6 |
| Alprazolam | 25 | $77 | $3 |
| Tramadol | 19 | $56 | $3 |
| Meloxicam | 11 | $43 | $4 |
| Clonazepam | 14 | $32 | $2 |
2020: 12 drugs
| Levothyroxine | 33 | $839 | $25 |
| Bupropion Xl | 14 | $509 | $36 |
| Atorvastatin | 26 | $508 | $20 |
| Omeprazole | 14 | $346 | $25 |
| Escitalopram | 14 | $262 | $19 |
| Lisinopril | 21 | $178 | $8 |
| Atenolol | 12 | $164 | $14 |
| Metformin | 13 | $139 | $11 |
| Nitrofurantoin Mono-Macro | 11 | $112 | $10 |
| Trazodone | 14 | $110 | $8 |
| Zolpidem | 11 | $56 | $5 |
| Lorazepam | 12 | $39 | $3 |
2017: 1 drug
| Hydrocodone-Acetaminophen | 16 | $279 | $17 |
Money from drug and device companies
$491 in 2025
| 2025 | 11 | 22 | None | $491 |
| 2024 | 9 | 22 | None | $447 |
| 2023 | 6 | 11 | None | $232 |
| 2022 | 1 | 1 | None | $30 |
| 2021 | 2 | 2 | None | $35 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Nurtec Odt | $82 | 5 payments
|
| Lilly USA | Mounjaro | $81 | 4 payments
|
| Novo Nordisk | Ozempic | $69 | 3 payments
|
| Exact Sciences | Cologuard Collection Kit | $66 | 2 payments
|
| Xeris Pharmaceuticals | Recorlev | $41 | 1 payment
|
| Merck Sharp & Dohme | Gardasil 9 | $34 | 1 payment
|
See all 22 published payments
| Xeris Pharmaceuticals | Meals · 2025-12-19 | Recorlev | $41 |
| Agios Pharmaceuticals | Meals · 2025-12-11 | Pyrukynd | $17 |
| Pfizer | Meals · 2025-11-21 | Nurtec Odt | $17 |
| Exact Sciences | Meals · 2025-11-17 | Cologuard Collection Kit | $32 |
| Astellas Pharma US | Meals · 2025-10-28 | Veozah | $33 |
| Lilly USA | Meals · 2025-09-22 | Mounjaro | $25 |
| Merck Sharp & Dohme | Meals · 2025-09-11 | Gardasil 9 | $34 |
| Lilly USA | Meals · 2025-09-08 | Mounjaro | $19 |
| Novo Nordisk | Meals · 2025-08-21 | Ozempic | $27 |
| Novo Nordisk | Meals · 2025-08-19 | None | $17 |
| Exact Sciences | Meals · 2025-08-11 | Cologuard Collection Kit | $34 |
| Lilly USA | Meals · 2025-07-21 | Zepbound | $23 |
| Novo Nordisk | Meals · 2025-07-17 | None | $25 |
| Pfizer | Meals · 2025-07-06 | Nurtec Odt | $18 |
| GlaxoSmithKline | Meals · 2025-06-23 | Shingrix | $20 |
| Pfizer | Meals · 2025-06-12 | Paxlovid | $17 |
| Lilly USA | Meals · 2025-03-19 | Mounjaro | $15 |
| Dynavax Technologies | Meals · 2025-03-10 | Heplisav-B | $0 |
| Dynavax Technologies | Meals · 2025-03-10 | Heplisav-B | $20 |
| Pfizer | Meals · 2025-03-03 | Paxlovid | $16 |
| Vanda Pharmaceuticals | Meals · 2025-02-13 | Hetlioz | $27 |
| Pfizer | Meals · 2025-01-24 | Nurtec Odt | $16 |
See earlier years (2024, 2023, 2022, 2021)
2024: $447
| Lilly USA | Mounjaro | $143 | 9 payments
|
| Vanda Pharmaceuticals | Hetlioz | $102 | 3 payments
|
| GlaxoSmithKline | Shingrix | $44 | 2 payments
|
| Pfizer | Nurtec Odt | $41 | 2 payments
|
| Abbvie | Linzess | $37 | 2 payments
|
| Novo Nordisk | Ozempic | $25 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $20 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Ofev | $20 | 1 payment
|
| Astellas Pharma US | Veozah | $15 | 1 payment
|
2023: $232
| Lilly USA | Mounjaro | $68 | 4 payments
|
| Exact Sciences | Cologuard Collection Kit | $63 | 3 payments
|
| GlaxoSmithKline | Shingrix | $32 | 1 payment
|
| Dynavax Technologies | Heplisav-B | $26 | 1 payment
|
| Novo Nordisk | Rybelsus | $23 | 1 payment
|
| Agile Therapeutics | Twirla | $20 | 1 payment
|
2022: $30
| GlaxoSmithKline | Shingrix | $30 | 1 payment
|
2021: $35
| AbbVie | Ubrelvy | $23 | 1 payment
|
| TherapeuticsMD | Annovera | $11 | 1 payment
|
Professional record
- NPI
- 1083168439
- Licence
- CA 95004436
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 1450 Treat Blvd # 300, Walnut Creek, CA, 94597
- NPI first listed
- 2016-08-14
- NPI last updated
- 2020-03-09
- NPI record certified
- 2020-03-09
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 500 E Remington Dr, Sunnyvale, CA, 94087